Compounds > fluorodeoxyglucose f18
Page last updated: 2024-08-24

fluorodeoxyglucose f18 and MEA 2a

fluorodeoxyglucose f18 has been researched along with MEA 2a in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Borrego-Dorado, I; Cuenca-Cuenca, JI; Gómez-Camarero, P; Navarro-González, E; Ortiz-de Tena, A; Ruiz-Franco-Baux, JV; Vázquez-Albertino, RJ1
Boér, A; Esik, O; Godény, M; Herzog, H; Kásler, M; Klein, I; Péter, I; Szakáll, S; Trón, L; Vincze, B1

Other Studies

2 other study(ies) available for fluorodeoxyglucose f18 and MEA 2a

ArticleYear
[Evaluation of efficacy and clinical impact of 18F-FDG-PET in the diagnosis of recurrent medullary thyroid cancer with increased calcitonin and negative imaging test].
    Revista espanola de medicina nuclear e imagen molecular, 2012, Volume: 31, Issue:5

    Topics: Biomarkers, Tumor; Bone Neoplasms; Calcitonin; Carcinoma, Medullary; Disease Progression; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Humans; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Multiple Endocrine Neoplasia Type 2b; Predictive Value of Tests; Radionuclide Imaging; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Thyroid Neoplasms; Thyroidectomy

2012
FDG PET imaging in hereditary thyroid cancer.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2003, Volume: 29, Issue:10

    Topics: Adolescent; Adult; Aged; Carcinoma, Medullary; Child; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple Endocrine Neoplasia Type 2a; Neoplasm Staging; Radiopharmaceuticals; Thyroid Neoplasms; Tomography, Emission-Computed

2003